 | • レポートコード：MRC2-11QY04228 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は持続性顔面紅斑治療のグローバル市場について調査・分析したレポートです。種類別（皮膚軟化剤、抗ヒスタミン薬、抗真菌薬、抗生物質、コルチコステロイド、カルシニューリン阻害薬）市場規模、用途別（病院、外来外科センター、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別持続性顔面紅斑治療の競争状況、市場シェア ・世界の持続性顔面紅斑治療市場：種類別市場規模 2015年-2020年（皮膚軟化剤、抗ヒスタミン薬、抗真菌薬、抗生物質、コルチコステロイド、カルシニューリン阻害薬） ・世界の持続性顔面紅斑治療市場：種類別市場規模予測 2021年-2026年（皮膚軟化剤、抗ヒスタミン薬、抗真菌薬、抗生物質、コルチコステロイド、カルシニューリン阻害薬） ・世界の持続性顔面紅斑治療市場：用途別市場規模 2015年-2020年（病院、外来外科センター、クリニック、その他） ・世界の持続性顔面紅斑治療市場：用途別市場規模予測 2021年-2026年（病院、外来外科センター、クリニック、その他） ・北米の持続性顔面紅斑治療市場分析：米国、カナダ ・ヨーロッパの持続性顔面紅斑治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの持続性顔面紅斑治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の持続性顔面紅斑治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの持続性顔面紅斑治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Anacor Pharmaceuticals、Astellas Pharma、Galderma、Meda Pharmaceuticals、Novartis、Pfizer、Regeneron Pharmaceuticals、Sanofi、Bausch Health ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Facial erythema is a very common reason for consulting a dermatologist.
While often a manifestation of a benign condition, in some cases facial erythema may be the first sign of a more serious disorder and specific diagnostic tests are needed to rule out these diseases.
Market Analysis and Insights: Global Persistent Facial Erythema Treatment Market
The global Persistent Facial Erythema Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Persistent Facial Erythema Treatment Scope and Market Size
Persistent Facial Erythema Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Persistent Facial Erythema Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Anacor Pharmaceuticals
Astellas Pharma
Galderma
Meda Pharmaceuticals
Novartis
Pfizer
Regeneron Pharmaceuticals
Sanofi
Bausch Health
Market segment by Type, the product can be split into
Emollients
Antihistamines
Antifungal
Antibiotics
Corticosteroids
Calcineurin Inhibitors
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Clinics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Persistent Facial Erythema Treatment Revenue
1.4 Market by Type
1.4.1 Global Persistent Facial Erythema Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Emollients
1.4.3 Antihistamines
1.4.4 Antifungal
1.4.5 Antibiotics
1.4.6 Corticosteroids
1.4.7 Calcineurin Inhibitors
1.5 Market by Application
1.5.1 Global Persistent Facial Erythema Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Clinics
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Persistent Facial Erythema Treatment Market Perspective (2015-2026)
2.2 Global Persistent Facial Erythema Treatment Growth Trends by Regions
2.2.1 Persistent Facial Erythema Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Persistent Facial Erythema Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Persistent Facial Erythema Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Persistent Facial Erythema Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Persistent Facial Erythema Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Persistent Facial Erythema Treatment Players by Market Size
3.1.1 Global Top Persistent Facial Erythema Treatment Players by Revenue (2015-2020)
3.1.2 Global Persistent Facial Erythema Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Persistent Facial Erythema Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Persistent Facial Erythema Treatment Market Concentration Ratio
3.2.1 Global Persistent Facial Erythema Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Persistent Facial Erythema Treatment Revenue in 2019
3.3 Persistent Facial Erythema Treatment Key Players Head office and Area Served
3.4 Key Players Persistent Facial Erythema Treatment Product Solution and Service
3.5 Date of Enter into Persistent Facial Erythema Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Persistent Facial Erythema Treatment Historic Market Size by Type (2015-2020)
4.2 Global Persistent Facial Erythema Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Persistent Facial Erythema Treatment Market Size by Application (2015-2020)
5.2 Global Persistent Facial Erythema Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Persistent Facial Erythema Treatment Market Size (2015-2020)
6.2 Persistent Facial Erythema Treatment Key Players in North America (2019-2020)
6.3 North America Persistent Facial Erythema Treatment Market Size by Type (2015-2020)
6.4 North America Persistent Facial Erythema Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Persistent Facial Erythema Treatment Market Size (2015-2020)
7.2 Persistent Facial Erythema Treatment Key Players in Europe (2019-2020)
7.3 Europe Persistent Facial Erythema Treatment Market Size by Type (2015-2020)
7.4 Europe Persistent Facial Erythema Treatment Market Size by Application (2015-2020)
8 China
8.1 China Persistent Facial Erythema Treatment Market Size (2015-2020)
8.2 Persistent Facial Erythema Treatment Key Players in China (2019-2020)
8.3 China Persistent Facial Erythema Treatment Market Size by Type (2015-2020)
8.4 China Persistent Facial Erythema Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Persistent Facial Erythema Treatment Market Size (2015-2020)
9.2 Persistent Facial Erythema Treatment Key Players in Japan (2019-2020)
9.3 Japan Persistent Facial Erythema Treatment Market Size by Type (2015-2020)
9.4 Japan Persistent Facial Erythema Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Persistent Facial Erythema Treatment Market Size (2015-2020)
10.2 Persistent Facial Erythema Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Persistent Facial Erythema Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Persistent Facial Erythema Treatment Market Size by Application (2015-2020)
11 India
11.1 India Persistent Facial Erythema Treatment Market Size (2015-2020)
11.2 Persistent Facial Erythema Treatment Key Players in India (2019-2020)
11.3 India Persistent Facial Erythema Treatment Market Size by Type (2015-2020)
11.4 India Persistent Facial Erythema Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Persistent Facial Erythema Treatment Market Size (2015-2020)
12.2 Persistent Facial Erythema Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Persistent Facial Erythema Treatment Market Size by Type (2015-2020)
12.4 Central & South America Persistent Facial Erythema Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Anacor Pharmaceuticals
13.1.1 Anacor Pharmaceuticals Company Details
13.1.2 Anacor Pharmaceuticals Business Overview
13.1.3 Anacor Pharmaceuticals Persistent Facial Erythema Treatment Introduction
13.1.4 Anacor Pharmaceuticals Revenue in Persistent Facial Erythema Treatment Business (2015-2020))
13.1.5 Anacor Pharmaceuticals Recent Development
13.2 Astellas Pharma
13.2.1 Astellas Pharma Company Details
13.2.2 Astellas Pharma Business Overview
13.2.3 Astellas Pharma Persistent Facial Erythema Treatment Introduction
13.2.4 Astellas Pharma Revenue in Persistent Facial Erythema Treatment Business (2015-2020)
13.2.5 Astellas Pharma Recent Development
13.3 Galderma
13.3.1 Galderma Company Details
13.3.2 Galderma Business Overview
13.3.3 Galderma Persistent Facial Erythema Treatment Introduction
13.3.4 Galderma Revenue in Persistent Facial Erythema Treatment Business (2015-2020)
13.3.5 Galderma Recent Development
13.4 Meda Pharmaceuticals
13.4.1 Meda Pharmaceuticals Company Details
13.4.2 Meda Pharmaceuticals Business Overview
13.4.3 Meda Pharmaceuticals Persistent Facial Erythema Treatment Introduction
13.4.4 Meda Pharmaceuticals Revenue in Persistent Facial Erythema Treatment Business (2015-2020)
13.4.5 Meda Pharmaceuticals Recent Development
13.5 Novartis
13.5.1 Novartis Company Details
13.5.2 Novartis Business Overview
13.5.3 Novartis Persistent Facial Erythema Treatment Introduction
13.5.4 Novartis Revenue in Persistent Facial Erythema Treatment Business (2015-2020)
13.5.5 Novartis Recent Development
13.6 Pfizer
13.6.1 Pfizer Company Details
13.6.2 Pfizer Business Overview
13.6.3 Pfizer Persistent Facial Erythema Treatment Introduction
13.6.4 Pfizer Revenue in Persistent Facial Erythema Treatment Business (2015-2020)
13.6.5 Pfizer Recent Development
13.7 Regeneron Pharmaceuticals
13.7.1 Regeneron Pharmaceuticals Company Details
13.7.2 Regeneron Pharmaceuticals Business Overview
13.7.3 Regeneron Pharmaceuticals Persistent Facial Erythema Treatment Introduction
13.7.4 Regeneron Pharmaceuticals Revenue in Persistent Facial Erythema Treatment Business (2015-2020)
13.7.5 Regeneron Pharmaceuticals Recent Development
13.8 Sanofi
13.8.1 Sanofi Company Details
13.8.2 Sanofi Business Overview
13.8.3 Sanofi Persistent Facial Erythema Treatment Introduction
13.8.4 Sanofi Revenue in Persistent Facial Erythema Treatment Business (2015-2020)
13.8.5 Sanofi Recent Development
13.9 Bausch Health
13.9.1 Bausch Health Company Details
13.9.2 Bausch Health Business Overview
13.9.3 Bausch Health Persistent Facial Erythema Treatment Introduction
13.9.4 Bausch Health Revenue in Persistent Facial Erythema Treatment Business (2015-2020)
13.9.5 Bausch Health Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Persistent Facial Erythema Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Persistent Facial Erythema Treatment Revenue
Table 3. Ranking of Global Top Persistent Facial Erythema Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Persistent Facial Erythema Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Emollients
Table 6. Key Players of Antihistamines
Table 7. Key Players of Antifungal
Table 8. Key Players of Antibiotics
Table 9. Key Players of Corticosteroids
Table 10. Key Players of Calcineurin Inhibitors
Table 11. Global Persistent Facial Erythema Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Persistent Facial Erythema Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Persistent Facial Erythema Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Persistent Facial Erythema Treatment Market Share by Regions (2015-2020)
Table 15. Global Persistent Facial Erythema Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Persistent Facial Erythema Treatment Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Persistent Facial Erythema Treatment Market Growth Strategy
Table 21. Main Points Interviewed from Key Persistent Facial Erythema Treatment Players
Table 22. Global Persistent Facial Erythema Treatment Revenue by Players (2015-2020) (Million US$)
Table 23. Global Persistent Facial Erythema Treatment Market Share by Players (2015-2020)
Table 24. Global Top Persistent Facial Erythema Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Persistent Facial Erythema Treatment as of 2019)
Table 25. Global Persistent Facial Erythema Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Persistent Facial Erythema Treatment Product Solution and Service
Table 28. Date of Enter into Persistent Facial Erythema Treatment Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Persistent Facial Erythema Treatment Market Size by Type (2015-2020) (Million US$)
Table 31. Global Persistent Facial Erythema Treatment Market Size Share by Type (2015-2020)
Table 32. Global Persistent Facial Erythema Treatment Revenue Market Share by Type (2021-2026)
Table 33. Global Persistent Facial Erythema Treatment Market Size Share by Application (2015-2020)
Table 34. Global Persistent Facial Erythema Treatment Market Size by Application (2015-2020) (Million US$)
Table 35. Global Persistent Facial Erythema Treatment Market Size Share by Application (2021-2026)
Table 36. North America Key Players Persistent Facial Erythema Treatment Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Persistent Facial Erythema Treatment Market Share (2019-2020)
Table 38. North America Persistent Facial Erythema Treatment Market Size by Type (2015-2020) (Million US$)
Table 39. North America Persistent Facial Erythema Treatment Market Share by Type (2015-2020)
Table 40. North America Persistent Facial Erythema Treatment Market Size by Application (2015-2020) (Million US$)
Table 41. North America Persistent Facial Erythema Treatment Market Share by Application (2015-2020)
Table 42. Europe Key Players Persistent Facial Erythema Treatment Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Persistent Facial Erythema Treatment Market Share (2019-2020)
Table 44. Europe Persistent Facial Erythema Treatment Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Persistent Facial Erythema Treatment Market Share by Type (2015-2020)
Table 46. Europe Persistent Facial Erythema Treatment Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Persistent Facial Erythema Treatment Market Share by Application (2015-2020)
Table 48. China Key Players Persistent Facial Erythema Treatment Revenue (2019-2020) (Million US$)
Table 49. China Key Players Persistent Facial Erythema Treatment Market Share (2019-2020)
Table 50. China Persistent Facial Erythema Treatment Market Size by Type (2015-2020) (Million US$)
Table 51. China Persistent Facial Erythema Treatment Market Share by Type (2015-2020)
Table 52. China Persistent Facial Erythema Treatment Market Size by Application (2015-2020) (Million US$)
Table 53. China Persistent Facial Erythema Treatment Market Share by Application (2015-2020)
Table 54. Japan Key Players Persistent Facial Erythema Treatment Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Persistent Facial Erythema Treatment Market Share (2019-2020)
Table 56. Japan Persistent Facial Erythema Treatment Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Persistent Facial Erythema Treatment Market Share by Type (2015-2020)
Table 58. Japan Persistent Facial Erythema Treatment Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Persistent Facial Erythema Treatment Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Persistent Facial Erythema Treatment Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Persistent Facial Erythema Treatment Market Share (2019-2020)
Table 62. Southeast Asia Persistent Facial Erythema Treatment Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Persistent Facial Erythema Treatment Market Share by Type (2015-2020)
Table 64. Southeast Asia Persistent Facial Erythema Treatment Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Persistent Facial Erythema Treatment Market Share by Application (2015-2020)
Table 66. India Key Players Persistent Facial Erythema Treatment Revenue (2019-2020) (Million US$)
Table 67. India Key Players Persistent Facial Erythema Treatment Market Share (2019-2020)
Table 68. India Persistent Facial Erythema Treatment Market Size by Type (2015-2020) (Million US$)
Table 69. India Persistent Facial Erythema Treatment Market Share by Type (2015-2020)
Table 70. India Persistent Facial Erythema Treatment Market Size by Application (2015-2020) (Million US$)
Table 71. India Persistent Facial Erythema Treatment Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Persistent Facial Erythema Treatment Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Persistent Facial Erythema Treatment Market Share (2019-2020)
Table 74. Central & South America Persistent Facial Erythema Treatment Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Persistent Facial Erythema Treatment Market Share by Type (2015-2020)
Table 76. Central & South America Persistent Facial Erythema Treatment Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Persistent Facial Erythema Treatment Market Share by Application (2015-2020)
Table 78. Anacor Pharmaceuticals Company Details
Table 79. Anacor Pharmaceuticals Business Overview
Table 80. Anacor Pharmaceuticals Product
Table 81. Anacor Pharmaceuticals Revenue in Persistent Facial Erythema Treatment Business (2015-2020) (Million US$)
Table 82. Anacor Pharmaceuticals Recent Development
Table 83. Astellas Pharma Company Details
Table 84. Astellas Pharma Business Overview
Table 85. Astellas Pharma Product
Table 86. Astellas Pharma Revenue in Persistent Facial Erythema Treatment Business (2015-2020) (Million US$)
Table 87. Astellas Pharma Recent Development
Table 88. Galderma Company Details
Table 89. Galderma Business Overview
Table 90. Galderma Product
Table 91. Galderma Revenue in Persistent Facial Erythema Treatment Business (2015-2020) (Million US$)
Table 92. Galderma Recent Development
Table 93. Meda Pharmaceuticals Company Details
Table 94. Meda Pharmaceuticals Business Overview
Table 95. Meda Pharmaceuticals Product
Table 96. Meda Pharmaceuticals Revenue in Persistent Facial Erythema Treatment Business (2015-2020) (Million US$)
Table 97. Meda Pharmaceuticals Recent Development
Table 98. Novartis Company Details
Table 99. Novartis Business Overview
Table 100. Novartis Product
Table 101. Novartis Revenue in Persistent Facial Erythema Treatment Business (2015-2020) (Million US$)
Table 102. Novartis Recent Development
Table 103. Pfizer Company Details
Table 104. Pfizer Business Overview
Table 105. Pfizer Product
Table 106. Pfizer Revenue in Persistent Facial Erythema Treatment Business (2015-2020) (Million US$)
Table 107. Pfizer Recent Development
Table 108. Regeneron Pharmaceuticals Company Details
Table 109. Regeneron Pharmaceuticals Business Overview
Table 110. Regeneron Pharmaceuticals Product
Table 111. Regeneron Pharmaceuticals Revenue in Persistent Facial Erythema Treatment Business (2015-2020) (Million US$)
Table 112. Regeneron Pharmaceuticals Recent Development
Table 113. Sanofi Business Overview
Table 114. Sanofi Product
Table 115. Sanofi Company Details
Table 116. Sanofi Revenue in Persistent Facial Erythema Treatment Business (2015-2020) (Million US$)
Table 117. Sanofi Recent Development
Table 118. Bausch Health Company Details
Table 119. Bausch Health Business Overview
Table 120. Bausch Health Product
Table 121. Bausch Health Revenue in Persistent Facial Erythema Treatment Business (2015-2020) (Million US$)
Table 122. Bausch Health Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Persistent Facial Erythema Treatment Market Share by Type: 2020 VS 2026
Figure 2. Emollients Features
Figure 3. Antihistamines Features
Figure 4. Antifungal Features
Figure 5. Antibiotics Features
Figure 6. Corticosteroids Features
Figure 7. Calcineurin Inhibitors Features
Figure 8. Global Persistent Facial Erythema Treatment Market Share by Application: 2020 VS 2026
Figure 9. Hospitals Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Clinics Case Studies
Figure 12. Others Case Studies
Figure 13. Persistent Facial Erythema Treatment Report Years Considered
Figure 14. Global Persistent Facial Erythema Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Persistent Facial Erythema Treatment Market Share by Regions: 2020 VS 2026
Figure 16. Global Persistent Facial Erythema Treatment Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Persistent Facial Erythema Treatment Market Share by Players in 2019
Figure 19. Global Top Persistent Facial Erythema Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Persistent Facial Erythema Treatment as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Persistent Facial Erythema Treatment Revenue in 2019
Figure 21. North America Persistent Facial Erythema Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Persistent Facial Erythema Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Persistent Facial Erythema Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Persistent Facial Erythema Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Persistent Facial Erythema Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Persistent Facial Erythema Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Persistent Facial Erythema Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed
化学療法薬誘発性肢端紅斑（手足症候群）治療の世界市場（～2026年） Acral erythema, also called as hand-foot syndrome or palmar-plantar erythrodysesthesia, is characterized by swelling, redness, paraesthesia (numbness) and desquamation (skin peeling) of palms, soles and rarely on knees and elbow. Acryl erythema is an adverse drug reaction which typically appear afte…- 顔面神経麻痺治療の世界市場（～2026年） Facial paralysis is a restriction of the facial movement due to nerve damage. Facial nerve paralysis is characterized by unilateral facial weakness. Some other symptoms include loss of taste, hyperacusis, and decreased salivation and tear secretion. The North American facial paralysis market is a gr…
- フェイシャルリンクルトリートメントの世界市場（～2026年） Facial wrinkle treatment involves procedures and medication intentional to delay, stop or retard the aging process. The rising geriatric population having age between 35-45 is the primary factor driving the growth of facial wrinkle treatment market. Market Analysis and Insights: Global Facial Wrinkl…
- 3D顔認識システムの世界市場（～2026年） 3D facial recognition is known to be the device in the world to be able to visually identify a person as easily as people identify one another. 3D facial recognition is an end-to-end electronic process that ensures customer convenience and compliance with several security regulations. The increased …
- 顔面脂肪移植の世界市場（～2026年） The Facial Fat Transfer is riding a wave of popularity and new advent technologies and procedures are lifted along with it. The market is growing with the rapid pace; mainly due to the increasing demand for facial fat transfer treatments and introduction of advanced technology in the facial rejuvena…